Barclays PLC Bausch Health Companies Inc. Call Options Transaction History

Barclays PLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $2.1 Million - $2.65 Million	-91,300 Reduced 43.83%	117,000 $3.23 Million
Q3 2021 Nov 09, 2021	BUY	$25.04 - $30.06 $5.21 Million - $6.26 Million	208,200 Added 208200.0%	208,300 $5.8 Million
Q4 2020 Feb 11, 2021	SELL	$15.31 - $21.12 $29,089 - $40,128	-1,900 Reduced 95.0%	100 $2,000
Q3 2020 Nov 12, 2020	SELL	$14.88 - $20.13 $452,352 - $611,952	-30,400 Reduced 93.83%	2,000 $31,000
Q2 2020 Aug 12, 2020	SELL	$13.31 - $20.51 $4.26 Million - $6.56 Million	-319,700 Reduced 90.8%	32,400 $593,000
Q1 2020 May 13, 2020	SELL	$12.98 - $30.25 $3.96 Million - $9.24 Million	-305,400 Reduced 46.45%	352,100 $5.46 Million
Q4 2019 Feb 10, 2020	BUY	$18.89 - $31.89 $4.7 Million - $7.93 Million	248,600 Added 60.8%	657,500 $19.7 Million
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $4.56 Million - $5.61 Million	-218,600 Reduced 34.84%	408,900 $8.93 Million
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $1.53 Million - $1.97 Million	74,500 Added 13.47%	627,500 $15.8 Million
Q1 2019 May 15, 2019	SELL	$20.23 - $26.29 $9.06 Million - $11.8 Million	-447,800 Reduced 44.74%	553,000 $13.7 Million
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $1.27 Million - $2.03 Million	71,800 Added 7.73%	1,000,800 $18.5 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $19.2 Million - $23.8 Million	929,000 New	929,000 $23.8 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.